quantic69/iStock via Getty Images
Alvotech (NASDAQ:ALVO) and Dr. Reddy’s Laboratories (NYSE:RDY) have entered into a collaboration and license agreement to co-develop, manufacture, and commercialize a biosimilar candidate to Keytruda (pembrolizumab) for global markets.
Keytruda (pembrolizumab) is indicated for the treatment of numerous cancer types. In 2024, worldwide sales
Missiles landed in several places in central and northern Israel, and dozens of people have been taken to hospital. ...
In a historic move, the UK government has named Blaise Metreweli as the next Chief of the Secret Intelligence Service—MI6—marking...
The man suspected of killing a Minnesota lawmaker and wounding another has been taken into custody, two law enforcement officials...
Mumbai: Former Reserve Bank of India deputy governor BP Kanungo is slated to join IIFL Finance as an independent director....
Stock futures were mixed on Sunday as investors weighed the impact of the escalating Israel-Iran conflict that shows no signs...
With Federal Reserve officials signaling an extended hold on interest rates, investors and economists will look to Chair Jerome Powell...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
